Baseline clinical features in a large-scale registration survey of patient with hypertrophic cardiomyopathy throughout Japan: J-HCM registry study
Abstract Background Hypertrophic cardiomyopathy (HCM) is a most prevalent primary myocardial disorder with heterogeneous clinical features. However, there have been few studies on clinical features of HCM as a prospective cohort. In 2015, we established a large-scale registration survey of patients...
Gespeichert in:
| Veröffentlicht in: | European heart journal 2020-11, Vol.41 (Supplement_2) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement_2 |
| container_start_page | |
| container_title | European heart journal |
| container_volume | 41 |
| creator | Kubo, T Takano, H Takayama, M Doi, Y.L Minami, Y Ebato, M Inomata, T Katoh, T Okamoto, R Chikamori, T Watanabe, E Furugen, A Maekwa, Y Shimizu, W Kitaoka, H |
| description | Abstract
Background
Hypertrophic cardiomyopathy (HCM) is a most prevalent primary myocardial disorder with heterogeneous clinical features. However, there have been few studies on clinical features of HCM as a prospective cohort. In 2015, we established a large-scale registration survey of patients with HCM throughout Japan, named J-HCM registry study.
Purpose
The aim of this study was to clarify the clinical features of Japanese patients with HCM.
Methods
J-HCM registry study is a prospective, multicenter investigation, consisting of 24 hospitals. This time, we present the baseline clinical characteristics in this survey.
Results
Total 1484 patients were registered. The ages at registration and at diagnosis were 65±15 and 56±17 years, respectively, and 806 patients (54%) were men. Majority of the patients (95%) was NYHA class I or II. With regard to subtypes of HCM, there were 526 patients (36%) in the HCM with left ventricular (LV) outflow tract obstruction, 126 patients (8%) in the mid-ventricular obstruction, 57 patients (4%) in the end-stage phase characterized by LV ejection fraction |
| doi_str_mv | 10.1093/ehjci/ehaa946.2085 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ehjci_ehaa946_2085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ehjci/ehaa946.2085</oup_id><sourcerecordid>10.1093/ehjci/ehaa946.2085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1255-74a7e2bd8d72706df622d09387434ee843fc70fceaf3be47b2f46a4976fc5dde3</originalsourceid><addsrcrecordid>eNqNkE1OwzAQhS0EEqVwAVa-QIrjOHbCDiqgVEVsQGIXufa4cZXGke2Acg1OTErLns0bad7P4kPoOiWzlJTZDdRbZUeVsmR8RkmRn6BJmlOalJzlp2hC0jJPOC8-ztFFCFtCSMFTPkHf9zJAY1vAalSrZIMNyNh7CNi2WOJG-g0kYTQAe9jYEL2M1rU49P4TBuwM7sYHtBF_2VjjeujAR--62iqspNfW7QY3RuoBx9q7flO7PuKl7GR7i5fJYv7ytzvgEHs9XKIzI5sAV8c7Re-PD2_zRbJ6fXqe360SldI8TwSTAuhaF1pQQbg2nFI9sigEyxhAwTKjBDEKpMnWwMSaGsYlKwU3Ktcasimih13lXQgeTNV5u5N-qFJS7alWv1SrI9VqT3UsJYeS67v_5H8AldaBNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Baseline clinical features in a large-scale registration survey of patient with hypertrophic cardiomyopathy throughout Japan: J-HCM registry study</title><source>Oxford University Press</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Kubo, T ; Takano, H ; Takayama, M ; Doi, Y.L ; Minami, Y ; Ebato, M ; Inomata, T ; Katoh, T ; Okamoto, R ; Chikamori, T ; Watanabe, E ; Furugen, A ; Maekwa, Y ; Shimizu, W ; Kitaoka, H</creator><creatorcontrib>Kubo, T ; Takano, H ; Takayama, M ; Doi, Y.L ; Minami, Y ; Ebato, M ; Inomata, T ; Katoh, T ; Okamoto, R ; Chikamori, T ; Watanabe, E ; Furugen, A ; Maekwa, Y ; Shimizu, W ; Kitaoka, H</creatorcontrib><description>Abstract
Background
Hypertrophic cardiomyopathy (HCM) is a most prevalent primary myocardial disorder with heterogeneous clinical features. However, there have been few studies on clinical features of HCM as a prospective cohort. In 2015, we established a large-scale registration survey of patients with HCM throughout Japan, named J-HCM registry study.
Purpose
The aim of this study was to clarify the clinical features of Japanese patients with HCM.
Methods
J-HCM registry study is a prospective, multicenter investigation, consisting of 24 hospitals. This time, we present the baseline clinical characteristics in this survey.
Results
Total 1484 patients were registered. The ages at registration and at diagnosis were 65±15 and 56±17 years, respectively, and 806 patients (54%) were men. Majority of the patients (95%) was NYHA class I or II. With regard to subtypes of HCM, there were 526 patients (36%) in the HCM with left ventricular (LV) outflow tract obstruction, 126 patients (8%) in the mid-ventricular obstruction, 57 patients (4%) in the end-stage phase characterized by LV ejection fraction <50%, and 197 patients (14%) in apical HCM. At registration, 80 patients (6%) had prior successful recovery from sustained ventricular tachycardia or ventricular fibrillation, 162 patients (11%) suffered from heart failure hospitalization, and 64 patients (4%) had history of embolic event. Regarding invasive treatment, 160 patients (10%) had prior septal reduction therapy and 162 patients (11%) had ICD implantation. According to the 2014 European Society of Cardiology Guidelines on sudden cardiac death (SCD) prevention, the study patients were divided into 3 categories by the HCM Risk-SCD calculator: patients distribution, 4% in the high risk group (≥6% calculated HCM Risk-SCD at 5 years), 7% in the intermediate risk group (4% to <6%), 69% in the low risk group (<4%), and 16% in the patients with extreme characteristics (Figure 1).
Conclusions
In this multicenter registration survey of patients with HCM, the baseline clinical characteristics were almost similar to several retrospective large-scale cohorts in Western countries except older age and less symptomatic state. This study will provide important knowledge regarding management of HCM.
Figure 1
Funding Acknowledgement
Type of funding source: None</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/ehjci/ehaa946.2085</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>European heart journal, 2020-11, Vol.41 (Supplement_2)</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kubo, T</creatorcontrib><creatorcontrib>Takano, H</creatorcontrib><creatorcontrib>Takayama, M</creatorcontrib><creatorcontrib>Doi, Y.L</creatorcontrib><creatorcontrib>Minami, Y</creatorcontrib><creatorcontrib>Ebato, M</creatorcontrib><creatorcontrib>Inomata, T</creatorcontrib><creatorcontrib>Katoh, T</creatorcontrib><creatorcontrib>Okamoto, R</creatorcontrib><creatorcontrib>Chikamori, T</creatorcontrib><creatorcontrib>Watanabe, E</creatorcontrib><creatorcontrib>Furugen, A</creatorcontrib><creatorcontrib>Maekwa, Y</creatorcontrib><creatorcontrib>Shimizu, W</creatorcontrib><creatorcontrib>Kitaoka, H</creatorcontrib><title>Baseline clinical features in a large-scale registration survey of patient with hypertrophic cardiomyopathy throughout Japan: J-HCM registry study</title><title>European heart journal</title><description>Abstract
Background
Hypertrophic cardiomyopathy (HCM) is a most prevalent primary myocardial disorder with heterogeneous clinical features. However, there have been few studies on clinical features of HCM as a prospective cohort. In 2015, we established a large-scale registration survey of patients with HCM throughout Japan, named J-HCM registry study.
Purpose
The aim of this study was to clarify the clinical features of Japanese patients with HCM.
Methods
J-HCM registry study is a prospective, multicenter investigation, consisting of 24 hospitals. This time, we present the baseline clinical characteristics in this survey.
Results
Total 1484 patients were registered. The ages at registration and at diagnosis were 65±15 and 56±17 years, respectively, and 806 patients (54%) were men. Majority of the patients (95%) was NYHA class I or II. With regard to subtypes of HCM, there were 526 patients (36%) in the HCM with left ventricular (LV) outflow tract obstruction, 126 patients (8%) in the mid-ventricular obstruction, 57 patients (4%) in the end-stage phase characterized by LV ejection fraction <50%, and 197 patients (14%) in apical HCM. At registration, 80 patients (6%) had prior successful recovery from sustained ventricular tachycardia or ventricular fibrillation, 162 patients (11%) suffered from heart failure hospitalization, and 64 patients (4%) had history of embolic event. Regarding invasive treatment, 160 patients (10%) had prior septal reduction therapy and 162 patients (11%) had ICD implantation. According to the 2014 European Society of Cardiology Guidelines on sudden cardiac death (SCD) prevention, the study patients were divided into 3 categories by the HCM Risk-SCD calculator: patients distribution, 4% in the high risk group (≥6% calculated HCM Risk-SCD at 5 years), 7% in the intermediate risk group (4% to <6%), 69% in the low risk group (<4%), and 16% in the patients with extreme characteristics (Figure 1).
Conclusions
In this multicenter registration survey of patients with HCM, the baseline clinical characteristics were almost similar to several retrospective large-scale cohorts in Western countries except older age and less symptomatic state. This study will provide important knowledge regarding management of HCM.
Figure 1
Funding Acknowledgement
Type of funding source: None</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkE1OwzAQhS0EEqVwAVa-QIrjOHbCDiqgVEVsQGIXufa4cZXGke2Acg1OTErLns0bad7P4kPoOiWzlJTZDdRbZUeVsmR8RkmRn6BJmlOalJzlp2hC0jJPOC8-ztFFCFtCSMFTPkHf9zJAY1vAalSrZIMNyNh7CNi2WOJG-g0kYTQAe9jYEL2M1rU49P4TBuwM7sYHtBF_2VjjeujAR--62iqspNfW7QY3RuoBx9q7flO7PuKl7GR7i5fJYv7ytzvgEHs9XKIzI5sAV8c7Re-PD2_zRbJ6fXqe360SldI8TwSTAuhaF1pQQbg2nFI9sigEyxhAwTKjBDEKpMnWwMSaGsYlKwU3Ktcasimih13lXQgeTNV5u5N-qFJS7alWv1SrI9VqT3UsJYeS67v_5H8AldaBNQ</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Kubo, T</creator><creator>Takano, H</creator><creator>Takayama, M</creator><creator>Doi, Y.L</creator><creator>Minami, Y</creator><creator>Ebato, M</creator><creator>Inomata, T</creator><creator>Katoh, T</creator><creator>Okamoto, R</creator><creator>Chikamori, T</creator><creator>Watanabe, E</creator><creator>Furugen, A</creator><creator>Maekwa, Y</creator><creator>Shimizu, W</creator><creator>Kitaoka, H</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20201101</creationdate><title>Baseline clinical features in a large-scale registration survey of patient with hypertrophic cardiomyopathy throughout Japan: J-HCM registry study</title><author>Kubo, T ; Takano, H ; Takayama, M ; Doi, Y.L ; Minami, Y ; Ebato, M ; Inomata, T ; Katoh, T ; Okamoto, R ; Chikamori, T ; Watanabe, E ; Furugen, A ; Maekwa, Y ; Shimizu, W ; Kitaoka, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1255-74a7e2bd8d72706df622d09387434ee843fc70fceaf3be47b2f46a4976fc5dde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kubo, T</creatorcontrib><creatorcontrib>Takano, H</creatorcontrib><creatorcontrib>Takayama, M</creatorcontrib><creatorcontrib>Doi, Y.L</creatorcontrib><creatorcontrib>Minami, Y</creatorcontrib><creatorcontrib>Ebato, M</creatorcontrib><creatorcontrib>Inomata, T</creatorcontrib><creatorcontrib>Katoh, T</creatorcontrib><creatorcontrib>Okamoto, R</creatorcontrib><creatorcontrib>Chikamori, T</creatorcontrib><creatorcontrib>Watanabe, E</creatorcontrib><creatorcontrib>Furugen, A</creatorcontrib><creatorcontrib>Maekwa, Y</creatorcontrib><creatorcontrib>Shimizu, W</creatorcontrib><creatorcontrib>Kitaoka, H</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kubo, T</au><au>Takano, H</au><au>Takayama, M</au><au>Doi, Y.L</au><au>Minami, Y</au><au>Ebato, M</au><au>Inomata, T</au><au>Katoh, T</au><au>Okamoto, R</au><au>Chikamori, T</au><au>Watanabe, E</au><au>Furugen, A</au><au>Maekwa, Y</au><au>Shimizu, W</au><au>Kitaoka, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Baseline clinical features in a large-scale registration survey of patient with hypertrophic cardiomyopathy throughout Japan: J-HCM registry study</atitle><jtitle>European heart journal</jtitle><date>2020-11-01</date><risdate>2020</risdate><volume>41</volume><issue>Supplement_2</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Abstract
Background
Hypertrophic cardiomyopathy (HCM) is a most prevalent primary myocardial disorder with heterogeneous clinical features. However, there have been few studies on clinical features of HCM as a prospective cohort. In 2015, we established a large-scale registration survey of patients with HCM throughout Japan, named J-HCM registry study.
Purpose
The aim of this study was to clarify the clinical features of Japanese patients with HCM.
Methods
J-HCM registry study is a prospective, multicenter investigation, consisting of 24 hospitals. This time, we present the baseline clinical characteristics in this survey.
Results
Total 1484 patients were registered. The ages at registration and at diagnosis were 65±15 and 56±17 years, respectively, and 806 patients (54%) were men. Majority of the patients (95%) was NYHA class I or II. With regard to subtypes of HCM, there were 526 patients (36%) in the HCM with left ventricular (LV) outflow tract obstruction, 126 patients (8%) in the mid-ventricular obstruction, 57 patients (4%) in the end-stage phase characterized by LV ejection fraction <50%, and 197 patients (14%) in apical HCM. At registration, 80 patients (6%) had prior successful recovery from sustained ventricular tachycardia or ventricular fibrillation, 162 patients (11%) suffered from heart failure hospitalization, and 64 patients (4%) had history of embolic event. Regarding invasive treatment, 160 patients (10%) had prior septal reduction therapy and 162 patients (11%) had ICD implantation. According to the 2014 European Society of Cardiology Guidelines on sudden cardiac death (SCD) prevention, the study patients were divided into 3 categories by the HCM Risk-SCD calculator: patients distribution, 4% in the high risk group (≥6% calculated HCM Risk-SCD at 5 years), 7% in the intermediate risk group (4% to <6%), 69% in the low risk group (<4%), and 16% in the patients with extreme characteristics (Figure 1).
Conclusions
In this multicenter registration survey of patients with HCM, the baseline clinical characteristics were almost similar to several retrospective large-scale cohorts in Western countries except older age and less symptomatic state. This study will provide important knowledge regarding management of HCM.
Figure 1
Funding Acknowledgement
Type of funding source: None</abstract><pub>Oxford University Press</pub><doi>10.1093/ehjci/ehaa946.2085</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-668X |
| ispartof | European heart journal, 2020-11, Vol.41 (Supplement_2) |
| issn | 0195-668X 1522-9645 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_ehjci_ehaa946_2085 |
| source | Oxford University Press; Alma/SFX Local Collection; EZB Electronic Journals Library |
| title | Baseline clinical features in a large-scale registration survey of patient with hypertrophic cardiomyopathy throughout Japan: J-HCM registry study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T18%3A53%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Baseline%20clinical%20features%20in%20a%20large-scale%20registration%20survey%20of%20patient%20with%20hypertrophic%20cardiomyopathy%20throughout%20Japan:%20J-HCM%20registry%20study&rft.jtitle=European%20heart%20journal&rft.au=Kubo,%20T&rft.date=2020-11-01&rft.volume=41&rft.issue=Supplement_2&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/ehjci/ehaa946.2085&rft_dat=%3Coup_cross%3E10.1093/ehjci/ehaa946.2085%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ehjci/ehaa946.2085&rfr_iscdi=true |